Here are relevant reports on : tissue-engineering-regeneration-market
-
Veterinary Surgical Instruments Market by Product (Sutures, Foreceps, Scissors, Electrosurgery Instruments, Cannulas), Animal (Canines, Felines, Large Animals), Application (Soft tissue, Sterilization, Gynecology, Orthopedic Surgery)- Global Forecast to 2021
The global veterinary surgical instruments market size is projected to grow at a CAGR of 6.6%. The increasing demand for veterinary surgical instruments is driven by the rising companion animal population coupled with the growing demand for pet insurance, the rising animal health awareness levels along with the increasing animal healthcare expenditure.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Orthopedic Biomaterials Market by Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, & Fracture Fixation) - Forecast to 2030
The orthopedic biomaterials market, valued at US$15.74 billion in 2024, stood at US$16.95 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$24.86 billion by the end of the period. This market encompasses load-bearing implants, bone cements, bioresorbable fixation devices, injectable viscoelastic gels, regenerative scaffolds, and specialized design-related services.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022
The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. The major players in the market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical.
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Breast Reconstruction Market Size, Growth by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) & Region - Global Forecasts to 2026
The global breast reconstruction market in terms of revenue was estimated to be worth $567 million in 2021 and is poised to reach $647 million by 2026, growing at a CAGR of 2.7% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: March 2022
- Price: $ 4950
- TOC Available:
-
Tissue Dissection Market by Method (Blunt, Sharp, Diathermy), Technology (Ultrasound, Electrosurgery, Hydromechanical, Pneumodissection), Product (Scissors, Needles, Hammers, Laser, RF), Application (Surgical, Diagnostic, Forensic) - Forecasts to 2022
The global Tissue Dissection market is poised to witness sustainable growth during the forecast period. As the number of surgical & clinical procedures is increasing every year along with rising criminal cases (including murder, homicide, & rape) market demand for these instruments will continue to grow for related forensic applications, over next decade. Furthermore, the introduction of minimally invasive products for tissue dissection and increasing demand and adoption of these technologies in surgical procedures are expected to provide additional growth opportunities for the market growth.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Electrotherapy Market by Treatment Type (TSE, IC, PSWD, TENS, SCS, EA, PENS), Application (Sports Injury, Tissue Repair, Pain Management), By End User (Hospitals, Clinics, Rehabilitation Centres) - Global Forecast to 2022
The global electrotherapy market is expected to reach $1,076.1 Million by 2022 from $902.5 Million in 2017, growing at a CAGR of 4.0% from 2017 to 2022. Increasing incidences of diabetes; technological advancements in electrotherapy systems; increasing obesity; and rising number of sports injuries are some of the major driving factors driving the growth of the global electrotherapy market. However, lack of awareness about the usage of electrotherapy systems in developing countries; availability of large number of substitutes; and saturation in developed countries are hindering the growth of this market.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Splicing Tapes Market by Resin (Acrylic, Rubber, Silicone), Backing Material (Paper/Tissue, Pet/Polyester, Non-Woven & Others), Application (Paper & Printing, Packaging, Electronics, Labeling), and Region - Forecast to 2023
The splicing tapes market size is projected to grow from USD 527 million in 2018 to USD 593 million by 2023, at a CAGR of 2.37% during the forecast period. There is a high demand for splicing tapes in the paper & printing and packaging industries due to the increase in population and digitalization in many parts of the globe. Digitalization process has driven the market of online shopping which has propelled the demand for packaging and labeling. Also, paper and paperboard packaging are gaining consumer’s attraction due to their effective solutions in food & beverages, healthcare, manufacturing, personal care, and other industries which is also driving the splicing tapes market.tesa SE (Germany), 3M Company (US), Nitto Denko Corporation (Japan), Avery Dennison Corporation (US), Intertape Polymer Group, Inc. (Canada), Scapa Group PLC (UK), Shurtape Technologies, PLC (US), ECHOtape (US), and Adhesive Research, Inc. (US). tesa SE (Germany)
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Stem Cell Therapy Market by Cell Source (Adipose Tissue, Bone Marrow, Placenta, Umbilical Cord, iPSC), Type (Autologus Stem Cell), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, Neurological), End User - Global Forecast to 2035
The global stem cell therapy market is projected to reach USD 3.65 billion by 2035 from USD 0.48 billion in 2026, at a CAGR of 25.3% during the forecast period. Key players in the stem cell therapy market include Vericel Corporation (US), Mesoblast (Australia), MEDIPOST (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), Anterogen Co., Ltd. (South Korea), CorestemChemon Inc. / Corestem, Inc. (South Korea), Vertex Pharmaceuticals (US), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate Srl (Italy), Stempeutics Research Pvt. Ltd. (India), Cipla Limited (India), Bayer AG (Germany), Aspen Neuroscience (US), Longeveron Inc. (US), and Smith+Nephew (UK).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Tissue Diagnostics Market by Product (Consumables [Antibodies, Kits, Reagents, Probes], Instruments [Systems, Scanner], Software, Services), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Global Forecast to 2030
The global Tissue Diagnostics market, valued at USD 6.19 billion in 2024, stood at USD 6.74 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of USD10.86 billion by the end of the period. The market growth is driven by the rising incidence of cancer and the growing demand for digital pathology, which are fueling the need for more accurate and high-throughput tissue-based diagnostics.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global stem cell manufacturing market, valued at US$12.0 billion in 2022, stood at US$12.7 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$21.8 billion by the end of the period. The major factors driving the growth of this market are technological advancements in stem cell manufacturing and the increasing prevalence of genetic disorders, both of which are expected to propel market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
